Background and Aims: Rectal resection in inflammatory bowel disease [IBD] is frequently complicated by disturbed perineal wound healing. Close rectal dissection, where the mesorectum remains in situ, is hypothesized to reduce complications by minimizing dead space, compared to total mesorectal excision. The aim of this study was to analyse post-operative outcomes of both techniques. In addition, immune activity in mesorectal tissue was assessed. Methods: Perineal complications and healing were retrospectively assessed in a series of 74 IBD patients undergoing proctectomy using close rectal dissection or total mesorectal excision. The mesorectums of 15 patients were analysed by fluorescence-activated cell sorting, immunofluorescence and in situ hybridization. Based on the clinical and in vitro findings, a novel surgical approach for Crohn's disease patients with disturbed perineal healing after proctectomy was developed. Results: In Crohn's disease, perineal complications were more frequent after close rectal dissection than after total mesorectal excision [59.5% vs 17.6%; p = 0.007] with lower healing rates [51.4% vs 88.2%; p = 0.014]. No differences were observed in ulcerative colitis. The mesorectal tissue in Crohn's disease contained enhanced numbers of tumour necrosis factor α-producing CD14 + macrophages, with less expression of the wound-healing marker CD206. Based on these findings, mesorectal excision with omentoplasty was performed in eight patients with perineal complications after close rectal dissection, resulting in complete perineal wound closure in six. Pro-inflammatory characteristics remained present in the mesorectum after close rectal dissection in these patients. Conclusions: In Crohn's disease, close rectal dissection resulted in more perineal complications, associated with a pro-inflammatory immune status of the mesorectal tissue. Excision of this proinflammatory mesenteric tissue resulted in improved perineal healing rates.
Introduction
Non-restorative proctectomy is performed in patients with severe inflammatory bowel disease [IBD] that is refractory to medical treatment. These patients are often debilitated and malnourished, with a subsequent risk of poor wound healing. Failed primary perineal wound healing is reported in >50% of patients with Crohn's disease, but less frequently in ulcerative colitis. [1] [2] [3] [4] [5] Other perineal complications include sepsis with presacral abscess and/or sinus formation. [6] [7] [8] [9] [10] Due to the benign nature of the disease, complete lymph node dissection according to oncological principles is not required in IBD. Therefore, close rectal dissection was proposed to improve postoperative outcome, 11 hypothesizing that leaving the mesorectum in situ would minimize pelvic dead space and reduce surgical site infections. Indeed, in a randomized control trial for ileal pouch-anal anastomosis in patients with ulcerative colitis, close rectal dissection resulted in a lower number of severe complications than total mesenteric excision. 12 In Crohn's disease, the ileal mesentery has been implicated in the pathology, as one of its hallmarks is the wrapping of mesenteric adipose tissue around the intestine [known as 'creeping fat']. 13, 14 Although this tissue is generally considered to be pathological, only scant literature is available regarding its composition and function. Some have suggested that the tissue might have a protective function. 15, 16 It is questionable whether the pathological characteristics of the creeping fat can be extrapolated to the mesorectum, because the presence of mesorectal adipose tissue is physiological and does not correlate with Crohn's disease specifically. Some changes in the mesentery have been described, 16 however, and mesenteric pathology has even been suggested to precede mucosal damage. 17 To date, no studies are available comparing the outcome of close rectal dissection and total mesorectal excision in Crohn's disease. Due to this lack of data, combined with the unknown inflammatory status of the mesorectal adipose tissue, it is unknown whether the advantages of smaller surgical trauma associated with close rectal dissection outweigh the disadvantages of leaving the mesorectum in situ.
In this study, perineal complications and wound healing were assessed after either total mesorectal dissection or close rectal excision in both ulcerative colitis and Crohn's disease. In addition, the mesorectum of both patient groups was analysed for immune activity. Based on the results, excision of the rectal mesentery was performed in eight Crohn's disease patients with a therapy-refractory presacral abscess after close rectal dissection proctectomy.
Materials and methods

Retrospective cohort study
Adult patients who underwent intersphincteric proctocolectomy or completion proctectomy for ulcerative colitis or Crohn's disease between January 2005 and January 2017 were included. There were no specific criteria for performing a total mesenteric excision vs a close rectal dissection, but the technique was changed over time. After the beginning of 2012, in an effort to decrease wound-healing complications by reducing post-operative dead space, a switch was made to close rectal dissection using a trans-anal or trans-abdominal minimally invasive surgical technique. Patients who received a reconstructive ileoanal pouch anastomosis were excluded.
End points in the retrospective cohort study
The main end points in this study were post-operative perineal complications, and perineal wound healing at 6 and 12 months. Perineal complications were recorded as wound infection, wound dehiscence, persisting sinus, presacral abscess, persisting perineal pain or perineal bleeding. Perineal wound healing was defined as complete closure of the surgical wound. 
Surgical excision of mesorectum in therapy-refractory presacral sinus
Crohn's disease patients with a therapy-refractory persistent perineal defect or recurrent presacral abscess after close rectal dissection were offered surgical excision of the mesorectum. These patients had been treated previously by conservative treatment [antibiotics, vacuum treatment], percutaneous drainage and local surgical interventions.
The presence and features of the sinus were investigated by radiological imaging. The presence of the omentum was confirmed by imaging. All procedures were performed by one or two consultants, with extensive experience in minimally invasive and redo colorectal surgery. A combined perineal and abdominal approach was used. The perineal phase was performed via trans-anal minimally invasive surgery [TAMIS] [for details about the TAMIS approach we refer to Borstlap et al] . 18 Abdominal exploration was required to mobilize the omentum and bring it down to the upper level of the external sphincter as a 'pull through' procedure to fill the pelvic cavity after total mesenteric excision. 
Statistical analysis
Mesorectal but not omental macrophages display decreased wound-healing-associated marker expression
Given the difference in perineal complications and healing rates between total mesorectal excision and close rectal dissection in Crohn's disease patients, fresh mesorectal tissue specimens were collected and cultured from a total of seven ulcerative colitis and eight Crohn's disease patients [ Table 4 ]. Because of the 48-h culture in medium containing serum, cells migrated out of the tissue specimens. These cells were analysed, and immune cells were identified by expression of CD45. In Crohn's disease mesorectum, the balance between CD3 + T cells and CD14 + myeloid cells was skewed significantly towards the myeloid population [ulcerative colitis vs Crohn's disease median 24% vs 46%, p < 0.05, Figure 1A] . In addition, the phenotype of the macrophages was different. In ulcerative colitis tissue, on average 25% of macrophages expressed the regulatory marker CD206 [ Figure 1B ]. In contrast, in Crohn's disease tissue, only 6% expressed this marker [p < 0.01]. Further analysis indicated that these differences were present irrespective of a preexisting non-functioning stoma [ Figure 1C , D]. In addition, Crohn's disease macrophages expressed higher levels of HLA-DR, decreased CD14 and comparable levels of CD64 [ Figure 1E ]. Similar differences were found in snap frozen tissue sections of ulcerative colitis and Crohn's disease mesorectum, with increased numbers of CD68 + macrophages in Crohn's disease, but almost no expression of CD206 [ Figure 1F ].
As a more functional read-out, transcription of TNFα was determined by in situ hybridization. In the resected intestine, TNFα mRNA was readily detectable both in ulcerative colitis and in Crohn's disease patients, consistent with active inflammation. However, the adjacent mesorectal tissue was nearly devoid of TNFα mRNA in ulcerative colitis, while clear expression was detected in Crohn's disease [ Figure 2A ]. Expression was located in adipocytes as well as in infiltrating cells, which mostly consisted of macrophages, as is shown by co-localization of TNFα mRNA with CD68 protein [ Figure 2B ].
After total mesenteric excision, omentoplasty is often performed to fill the resulting void. As the omentum is also composed of adipose tissue, the macrophage compartment of this tissue in Crohn's disease patients was analysed and compared to non-IBD controls. The expression of wound-healing markers in the omentum did not differ significantly between Crohn's disease and non-IBD [ Figure 2C ], which suggests that the macrophage alterations observed in the mesorectum do not extend to the omentum.
Perineal healing after excision of the mesorectum
Given the pro-inflammatory profile of the mesorectum in Crohn's disease, it was hypothesized that this tissue contributes to the disturbed healing observed in these patients. Therefore, eight Crohn's disease patients [one male] with persistent perineal wounds after close rectal dissection were offered excision of the mesorectum with omentoplasty, as described in Methods.
Excision of the rectal mesentery was performed after a median total disease duration of 18 Table 5 . No residual mucosa was found in their surgical specimens.
After the 6-month follow-up, five out of eight [63%] had a closed perineal wound, and at the time of the last follow-up, healing of the perineum had occurred in six out of eight patients [75%] [ Figure 3A ]. The two patients without perineal healing only had superficial defects, without a pre-sacral abscess. Two patients underwent re-laparotomy within 30 days: one developed an ileus, as a result of an internal herniation under the omentoplasty, and one patient had a post-operative incarcerated parastomal hernia. There were no re-interventions for perineal complications. Further analysis of the mesorectum of these patients showed a similar CD206 ratio as observed before in Crohn's disease patients [ Figure 3B , C]. Upon histological examination, clear cellular infiltrates were seen with high expression of TNFα mRNA, which is consistent with a persistent inflammatory response [ Figure 3D ].
Discussion
Although close rectal dissection was introduced to reduce complications in IBD patients by leaving the rectal mesentery in situ to reduce pelvic dead space, the present study shows the opposite result for Crohn's disease patients. In this population, perineal complications increased almost three-fold after close rectal dissection as compared to total mesorectal excision. Further support of a pro-inflammatory role for the mesorectum was provided by the fact that excision of the mesorectum resulted in perineal wound closure within months, even after years of perineal complications.
The present study is the first to focus on the rectal mesentery rather than small bowel or colon mesentery in IBD. In contrast to creeping fat, no pathological changes in the mesorectum have been described in Crohn's disease. However, the decreased healing observed after close rectal dissection suggested a pathogenic role for the mesorectal tissue. This was indeed confirmed, as the composition of the immune component within the adipose tissue differed significantly between ulcerative colitis and Crohn's disease. In ulcerative colitis, fewer myeloid cells were present, and cells within the myeloid compartment had a more anti-inflammatory phenotype. This was consistent with preliminary data regarding the phenotype in non-IBD tissue [data not shown]. Although the number of patients was limited, pro-inflammatory characteristics were consistently found in Crohn's disease mesorectum regardless of defunctioning. They remained present after close rectal dissection, which suggests that this phenotype is not a mere reflection of the inflammatory status of the intestine. As tissue healing requires a shift from a pro-inflammatory to an anti-inflammatory tissue status, the inflammatory phenotype in Crohn's disease mesorectum may contribute to impaired healing when left in situ. 19 Regulatory macrophages are considered to play a crucial role in wound healing by suppression of ongoing inflammation and stimulation of epithelial repair. Interestingly, it has previously been shown that anti-TNFα treatment induces regulatory macrophages with wound healing properties both in vitro and in vivo in IBD patients. 20, 21 Consistent with its pathogenic role in Crohn's disease, increased TNFα production has been demonstrated in adipose tissue. 13 In line with this finding, the macrophages present in Crohn's disease mesorectum also expressed clear levels of TNFα in our study.
The finding of an ongoing pro-inflammatory phenotype in Crohn's disease, despite defunctioning, led to the hypothesis that excision of the mesorectum could be beneficial in Crohn's disease patients with recurrent perineal sepsis after close rectal dissection. This experimental intervention in a therapy-refractory patient group did indeed show promising results. After a median of 8 years of ongoing perineal complications, perineal healing was achieved within 6 months in the majority of patients. To improve wound healing, the presacral cavity should be filled with well-vascularized tissue. In the literature, myocutaneous flaps, such as the vertical rectus abdominis muscle flap and the gracilis flap, have been described, but they may cause morbidity at the donor site and can undergo necrosis. 22 Despite the fact that both mesentery and omentum derive from the same embryonic structure, the omentum in Crohn's disease patients did not show the same abnormalities as the mesentery. For this reason, an omentoplasty is preferred after excision of the mesentery. A limitation of this study is its partially retrospective design. Furthermore, tissue analysis was performed on only a subset of patients. Despite the small numbers, however, macrophage distribution in ulcerative colitis and Crohn's disease mesorectum showed substantial differences and clustered clearly in either disease. In addition, patients were included in this analysis based on sequential time of surgery, thus eliminating selection bias with regard to, for example, disease severity, prior surgical interventions or medication use. Due to the relatively small sample size, extensive multivariate analysis including these parameters was precluded. However, further stratification in patients receiving or not receiving anti-TNF did not show any differences between these groups, either numerically or statistically [data not shown].
In most practices total mesenteric excision is performed, because close rectal dissection proctectomy can be technically challenging. For Crohn's disease patients total mesenteric excision remains the preferred technique. For ulcerative colitis patients, further studies should determine whether close rectal dissection leads to better healing rates, as this current study does not provide sufficient evidence to rule out a beneficial effect of this procedure in ulcerative colitis.
The results found in this study could also be applicable to other parts of the intestine, such as the terminal ileum. This is confirmed by the recent finding that excision of the mesentery in ileocolic resection is associated with fewer surgical recurrences. 23 In conclusion, this study provides evidence that the mesorectum does play a role in perineal wound healing in Crohn's disease, based on both surgical and laboratory data. More than 50% of Crohn's disease patients had perineal complications and impaired wound healing after proctectomy, particularly after close rectal dissection. The mesorectum in Crohn's disease patients showed a particularly pro-inflammatory subset of immune cells, providing a biological rationale for improved outcomes after total mesenteric excision, as well as the benefits of secondary excision for patients having persistent perineal complications after proctectomy. The latter was subsequently confirmed in a first-in-kind case series. Using a translational approach of both clinical and laboratory investigations, these data indicate that excision of the mesorectum is of crucial importance in Crohn's disease proctectomy, whereas close rectal dissection should be the treatment of choice for ulcerative colitis.
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